APA (7th ed.) Citation

Hudalla, H., Karmen, C., Bruckner, T., Wallwiener, S., Fluhr, H., Freis, A., . . . Kuon, R. (2018). Tocolysis with the β2-sympathomimetic fenoterol does not increase the occurrence of infantile hemangioma in preterm and term infants. Archives of gynecology and obstetrics, 298(3), . https://doi.org/10.1007/s00404-018-4830-5

Chicago Style (17th ed.) Citation

Hudalla, Hannes, Christian Karmen, Thomas Bruckner, Stephanie Wallwiener, Herbert Fluhr, Alexander Freis, Thomas Strowitzki, Johannes Pöschl, and Ruben-Jeremias Kuon. "Tocolysis with the β2-sympathomimetic Fenoterol Does Not Increase the Occurrence of Infantile Hemangioma in Preterm and Term Infants." Archives of Gynecology and Obstetrics 298, no. 3 (2018). https://doi.org/10.1007/s00404-018-4830-5.

MLA (9th ed.) Citation

Hudalla, Hannes, et al. "Tocolysis with the β2-sympathomimetic Fenoterol Does Not Increase the Occurrence of Infantile Hemangioma in Preterm and Term Infants." Archives of Gynecology and Obstetrics, vol. 298, no. 3, 2018, https://doi.org/10.1007/s00404-018-4830-5.